Turkey Biomaterials in Healthcare Market Analysis Report [2022-30] I Insights10

Turkey Biomaterials in Healthcare Market Analysis

$ 3999

The Turkey Biomaterials in Healthcare Market is expected to witness growth from $1.25 Bn in 2022 to $3.49 Bn in 2030 with a CAGR of 13.70% for the forecasted year 2022-2030. Turkey has been spending more on healthcare recently, with the government making investments in brand-new hospitals, clinics, and medical equipment. The demand for medical equipment and biomaterials, which are essential for patient care, has grown as a result of this investment. The market is segmented by type and by application. Some key players in this market include: Acibadem Labmed, Megasan Medikal, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.

ID: IN10TRMD003 CATEGORY: Medical Devices GEOGRAPHY: Turkey AUTHOR: Jigyasu Bhandari

Buy Now

Turkey Biomaterials in Healthcare Market Executive Analysis

The Turkey Biomaterials in Healthcare Market size is at around $1.25 Bn in 2022 and is projected to reach $3.49 Bn in 2030, exhibiting a CAGR of 13.70% during the forecast period. Turkey spent $13.7 Bn on healthcare overall in 2020, a 24.3% increase over 2019. Spending on health across the board rose by 26.3% to $10.48 Bn. Private sector healthcare spending was projected to total $2.70 Bn, an increase of 17.3%. In 2020, the federal government accounted for 79.2% of all health expenditures, compared to 20.8% from the private sector.

In Turkey, drug delivery systems that can be used to transport medications and other therapeutic agents directly to sick tissues and organs are created using biomaterials. With less side effects, this method enables more targeted and efficient disease treatment. In Turkey, the use of biomaterials in drug delivery methods has resulted in better patient outcomes and lower medical expenses. In regenerative medicine, biomaterials are utilized to encourage tissue and organ regeneration and healing. Numerous conditions, such as spinal nerve injuries, heart disease, and diabetes, are treated using this strategy. Researchers have created novel treatments and therapies that have the potential to revolutionize healthcare thanks to the use of biomaterials in regenerative medicine in Turkey. Implantable devices like orthopaedic implants, oral implants, and cardiovascular implants are created using biomaterials. These tools aid in regaining function for tissues and systems that have been damaged or are ill. Turkey's implantable devices now use biomaterials, which has enhanced patient outcomes and sped up recovery periods.

turkey biomaterials in healthcare market

Market Dynamics

Market Growth Drivers

Turkey has been spending more on healthcare recently, with the government making investments in brand-new hospitals, clinics, and medical equipment. The demand for medical equipment and biomaterials, which are essential for patient care, has grown as a result of this investment. Turkey's population is aging quickly, with the proportion of people over 65 anticipated to rise sharply in the coming years. The demand for medical devices and biomaterials is anticipated to increase as a result of this demographic change, especially in fields like orthopaedics, cardiovascular disease, and tissue engineering. Turkey is experiencing an increase in the prevalence of illnesses like diabetes, heart disease, and cancer, which is fueling demand for medical equipment and biomaterials used to treat these conditions. The Biomaterials in Healthcare industry in Turkey is home to producers who are working to create products that will help patients achieve better results while spending less money overall on their care.

Market Restraints

There is fierce competition among Biomaterials manufacturers for market share in Turkey's healthcare sector. This could place pressure on prices, especially for commodities, which could limit biomaterials manufacturers ability to increase sales and profit margins. Economic unpredictability in Turkey has recently had an effect on healthcare spending and growth prospects for manufacturers in the Biomaterials in Healthcare market.

Competitive Landscape

Key Players

Acibadem Labmed (TR)
Megasan Medikal (TR)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Healthcare Policies and Regulatory Landscape

The Turkish Ministry of Health (MoH) oversees the country's healthcare system. The creation and execution of healthcare regulations, as well as the control of biomaterials products, fall under the purview of the MoH. The regulatory authority in charge of registering, assessing, and overseeing medical devices and biomaterials products in Turkey is the Turkish Medicines and Medical Devices Agency (TITCK). Inspecting manufacturing facilities and enforcing laws pertaining to medical device and biomaterials goods are additional responsibilities of the TITCK. Manufacturers are also required by the TITCK to adhere to particular labeling and packaging specifications for goods containing medical devices and biomaterials. To reduce the chance of negative events and guarantee patient safety, these requirements are meant to make sure that products are packaged and labelled correctly.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Turkey market in 2019. The growing geriatric population Turkeyly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.